TRDA

Entrada Therapeutics Inc (TRDA)

US
$ 8.84-1.34%

Price Chart

Key Statistics

Market Cap
$ 334.75M
P/E Ratio
5.25
Revenue (TTM)
$ 210.78M
Volume
95.96K
52W High
$ 21.79
52W Low
$ 7.10
Dividend Yield
0.00%
Beta
0.03

Technicals

50-Day MA
9.5083
200-Day MA
14.5524
52 Week High
21.79
52 Week Low
7.1

About TRDA

Entrada Therapeutics, Inc., a clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases.

Employees
183
Headquarters
Boston, MA
CEO
Mr. Dipal Doshi

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Losers

Symbol/Name
LTP
% Chg